OUE Lippo Healthcare FY17 losses widen to $90.7 mil on lower revenue & higher costs

OUE Lippo Healthcare FY17 losses widen to $90.7 mil on lower revenue & higher costs

By: 
Michelle Zhu
12/02/18, 11:30 pm

SINGAPORE (Feb 12): OUE Lippo Healthcare further sunk into the red in FY17 with a loss of $90.7 million, 18% down from its loss of $76.8 million the previous year on lower revenue and higher costs of sales.

Revenue for the full year declined 11.2% to $43.6 million, due mainly to lower rental contributions from investment properties in Australia. This was however partially offset by higher contributions from operating Wuxi New District Phoenix Hospital, while income from the group’s nursing facilities In Japan remained stable.   

A higher operating loss of $62.7 million was reported in comparison to $58 million in FY16, mainly due to the absence of a one-off net gain on deconsolidating of subsidiaries recorded in the previous year, which was related to deconsolidation of assets & liabilities related to the group’s IHC subsidiaries.

Meanwhile, administrative expenses grew 36.9% to $18.3 million from $13.4 million a year ago, due to higher legal and professional fees incurred from corporate activities and ongoing litigations.

In its outlook, OUE Lippo highlights its recent acquisition by Japan’s Itochu Corporation, and says the share placement taking place this month will strengthen the group’s financial position while putting it in good stead to execute its business plans ahead.

See: Japan's Itochu acquires 25.3% stake in OUE Lippo Healthcare for $79 mil

Aside from strengthening its presence in China while also expanding into new markets in Southeast Asia, OUE Lippo says it also plans to leverage on the strengths of its major shareholders, including OUE and Itochu, and forge partnerships with local or industry leaders, such as China Merchants Group and SK Telecom.

Shares in OUE Lippo closed 2.2% lower at 13 cents on Monday. 

Time to 'buy' MindChamps as growth initiatives bear fruit: RHB

SINGAPORE (May 27): RHB Research continues to keep MindChamps Preschool at “buy” at a lower target price of 83 cents compared to 87 cents previously, indicating a 26% upside plus 2.2% yield. The reduced target price comes after cutting FY19-20F earnings by 7% and 11%, respectively, upon management indications that adopting SFRS 16 has negatively impacted the group’s 1Q19 pre-tax profit by about $90 million or -15%. In a May 17 report, analyst Juliana Cai says she nonetheless remains positive on MindChamps as she expects the group to start reaping returns from its investments as its....
Read More >>

Ascendas-Singbridge establishes co-innovation lab with IMDA & Enterprise Singapore

SINGAPORE (May 27): Singapore’s smart nation ambitions have been further bolstered by a new partnership between Ascendas-Singbridge, Infocomm Development Authority of Singapore (IMDA) and Enterprise Singapore (ESG) to form the Smart Urban Co-Innovation Lab. All three parties are looking to have a total of 30 co-innovation projects come out from the lab, which is expected to be launched at the end of the year as the first developer-led lab in Southeast Asia. This announcement follows last year’s call for innovation led by IMDA, Ascendas and JTC. Ascendas has published 12 probl....
Read More >>

Frasers Centrepoint Trust poised to ride on popularity of suburban retail malls, analysts say

SINGAPORE (May 27): Suburban retail malls are quickly gaining favour in Singapore, stealing local visitors away from the famed Orchard Road shopping belt. And Frasers Centrepoint Trust (FCT), which currently owns a portfolio of six suburban malls, looks poised to capitalise on this trend. Already in FCT’s suburban mall portfolio are Causeway Point, Northpoint City North Wing, Changi City Point, YewTee Point, Anchorpoint, and Bedok Point. The retail REIT has also proposed to acquire the one-third interest in Sapphire Star Trust, which owns the Waterway Point mall in Punggol, from its sp....
Read More >>